key: cord-0824951-0x27i4qo
authors: Hanage, William P; Vincent, Victor I; Low, Nicola M
title: Seroprevalence of SARS-CoV-2 in Hong Kong returnees
date: 2020-08-06
journal: Lancet Microbe
DOI: 10.1016/s2666-5247(20)30099-9
sha: de8eb5c57d3d8e0e37e33545608d7d5694edf5a9
doc_id: 824951
cord_uid: 0x27i4qo

nan

The estimate for Wuhan is consistent with the summary estimate preprinted in a systematic review (0·66%, 95% CI 0·52-0·8%) of studies worldwide. 3 The reporting of the data in this study raises three important issues. First, we should expect estimates of the IFR in different countries and communities to vary because of differences in age structure and other risk factors, but not to the extent shown in this example. Second, singlepoint estimates of seroprevalence are not reliable when estimating the IFR because of multiple sources of uncertainty including diagnostic test accuracy, the timing of a study during the epidemic, and the precise sampling strategy used. 4 Third, study results including estimates of the IFR should be presented transparently, with all assumptions, in the results section, rather than in the discussion. Reconsideration of the data reported in the paper shows that the findings of this study are in fact congruent with those from elsewhere.

Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study

COVID-19 pandemic in Hubei

A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates

Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys